Exact Mass: 507.1925
Exact Mass Matches: 507.1925
Found 500 metabolites which its exact mass value is equals to given mass value 507.1925
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tyr-Tyr-Tyr
(2E)-3-[2,3-dihydro-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-1,4-benzodioxin-6-yl]-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide|thoreliamide B
Ala Cys Glu Trp
Ala Cys Trp Glu
Ala Glu Cys Trp
Ala Glu Trp Cys
Ala Met Thr Trp
Ala Met Trp Thr
Ala Thr Met Trp
Ala Thr Trp Met
Ala Trp Cys Glu
Ala Trp Glu Cys
Ala Trp Met Thr
Ala Trp Thr Met
Cys Ala Glu Trp
Cys Ala Trp Glu
Cys Asp Asp Arg
Cys Asp Arg Asp
Cys Glu Ala Trp
Cys Glu Glu Lys
Cys Glu Lys Glu
Cys Glu Arg Thr
Cys Glu Thr Arg
Cys Glu Trp Ala
Cys Ile Ser Trp
Cys Ile Trp Ser
Cys Lys Glu Glu
Cys Leu Ser Trp
Cys Leu Trp Ser
Cys Arg Asp Asp
Cys Arg Glu Thr
Cys Arg Thr Glu
Cys Ser Ile Trp
Cys Ser Leu Trp
Cys Ser Trp Ile
Cys Ser Trp Leu
Cys Thr Glu Arg
Cys Thr Arg Glu
Cys Thr Val Trp
Cys Thr Trp Val
Cys Val Thr Trp
Cys Val Trp Thr
Cys Trp Ala Glu
Cys Trp Glu Ala
Cys Trp Ile Ser
Cys Trp Leu Ser
Cys Trp Ser Ile
Cys Trp Ser Leu
Cys Trp Thr Val
Cys Trp Val Thr
Asp Cys Asp Arg
Asp Cys Arg Asp
Asp Asp Cys Arg
Asp Asp Lys Met
Asp Asp Met Lys
Asp Asp Arg Cys
Asp Gly Met Trp
Asp Gly Trp Met
Asp Lys Asp Met
Asp Lys Met Asp
Asp Met Asp Lys
Asp Met Gly Trp
Asp Met Lys Asp
Asp Met Arg Ser
Asp Met Ser Arg
Asp Met Trp Gly
Asp Asn Pro Tyr
Asp Asn Tyr Pro
Asp Pro Asn Tyr
Asp Pro Tyr Asn
Asp Arg Cys Asp
Asp Arg Asp Cys
Asp Arg Met Ser
Asp Arg Ser Met
Asp Ser Met Arg
Asp Ser Arg Met
Asp Ser Thr Trp
Asp Ser Trp Thr
Asp Thr Ser Trp
Asp Thr Trp Ser
Asp Trp Gly Met
Asp Trp Met Gly
Asp Trp Ser Thr
Asp Trp Thr Ser
Asp Tyr Asn Pro
Asp Tyr Pro Asn
Glu Ala Cys Trp
Glu Ala Trp Cys
Glu Cys Ala Trp
Glu Cys Glu Lys
Glu Cys Lys Glu
Glu Cys Arg Thr
Glu Cys Thr Arg
Glu Cys Trp Ala
Glu Glu Cys Lys
Glu Glu Lys Cys
Glu Lys Cys Glu
Glu Lys Glu Cys
Glu Met Gln Thr
Glu Met Thr Gln
Glu Gln Met Thr
Glu Gln Thr Met
Glu Arg Cys Thr
Glu Arg Thr Cys
Glu Ser Ser Trp
Glu Ser Trp Ser
Glu Thr Cys Arg
Glu Thr Met Gln
Glu Thr Gln Met
Glu Thr Arg Cys
Glu Trp Ala Cys
Glu Trp Cys Ala
Glu Trp Ser Ser
Phe Met Asn Pro
Phe Met Pro Asn
Phe Asn Met Pro
Phe Asn Asn Asn
Phe Asn Pro Met
Phe Pro Met Asn
Phe Pro Asn Met
Gly Asp Met Trp
Gly Asp Trp Met
Gly Met Asp Trp
Gly Met Trp Asp
Gly Trp Asp Met
Gly Trp Met Asp
His His Asn Thr
His His Gln Ser
His His Ser Gln
His His Thr Asn
His Asn His Thr
His Asn Thr His
His Gln His Ser
His Gln Ser His
His Ser His Gln
His Ser Gln His
His Thr His Asn
His Thr Asn His
Ile Cys Ser Trp
Ile Cys Trp Ser
Ile Met Met Asn
Ile Met Asn Met
Ile Asn Met Met
Ile Ser Cys Trp
Ile Ser Trp Cys
Ile Trp Cys Ser
Ile Trp Ser Cys
Lys Cys Glu Glu
Lys Asp Asp Met
Lys Asp Met Asp
Lys Glu Cys Glu
Lys Glu Glu Cys
b-D-Glucopyranosiduronic acid, 4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxyphenyl, (3S-tr
Lys Met Asp Asp
5-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxy-, (3S-trans)-Phenol glucuronide
Leu Cys Ser Trp
Leu Cys Trp Ser
Leu Met Met Asn
Leu Met Asn Met
Leu Asn Met Met
Leu Ser Cys Trp
Leu Ser Trp Cys
Leu Trp Cys Ser
Leu Trp Ser Cys
Met Ala Thr Trp
Met Ala Trp Thr
Met Asp Asp Lys
Met Asp Gly Trp
Met Asp Lys Asp
Met Asp Arg Ser
Met Asp Ser Arg
Met Asp Trp Gly
Met Glu Gln Thr
Met Glu Thr Gln
Met Phe Asn Pro
Met Phe Pro Asn
Met Gly Asp Trp
Met Gly Trp Asp
Met Ile Met Asn
Met Ile Asn Met
Met Lys Asp Asp
Met Leu Met Asn
Met Leu Asn Met
Met Met Ile Asn
Met Met Leu Asn
Met Met Asn Ile
Met Met Asn Leu
Met Met Gln Val
Met Met Val Gln
Met Asn Phe Pro
Met Asn Ile Met
Met Asn Leu Met
Met Asn Met Ile
Met Asn Met Leu
Met Asn Pro Phe
Met Pro Phe Asn
Met Pro Asn Phe
Met Gln Glu Thr
Met Gln Met Val
Met Gln Thr Glu
Met Gln Val Met
Met Arg Asp Ser
Met Arg Ser Asp
Met Ser Asp Arg
Met Ser Arg Asp
Met Thr Ala Trp
Met Thr Glu Gln
Met Thr Gln Glu
Met Thr Trp Ala
Met Val Met Gln
Met Val Gln Met
Met Trp Ala Thr
Met Trp Asp Gly
Met Trp Gly Asp
Met Trp Thr Ala
Asn Asp Pro Tyr
Asn Asp Tyr Pro
Asn Phe Met Pro
Asn Phe Asn Asn
Asn Phe Pro Met
Asn His His Thr
Asn His Thr His
Asn Ile Met Met
Asn Leu Met Met
Asn Met Phe Pro
Asn Met Ile Met
Asn Met Leu Met
Asn Met Met Ile
Asn Met Met Leu
Asn Met Pro Phe
Asn Asn Phe Asn
Asn Asn Asn Phe
Asn Pro Asp Tyr
Asn Pro Phe Met
Asn Pro Met Phe
Asn Pro Tyr Asp
Asn Thr His His
Asn Tyr Asp Pro
Asn Tyr Pro Asp
Pro Asp Asn Tyr
Pro Asp Tyr Asn
Pro Phe Met Asn
Pro Phe Asn Met
Pro Met Phe Asn
Pro Met Asn Phe
Pro Asn Asp Tyr
Pro Asn Phe Met
Pro Asn Met Phe
Pro Asn Tyr Asp
Pro Tyr Asp Asn
Pro Tyr Asn Asp
Gln Glu Met Thr
Gln Glu Thr Met
Gln His His Ser
Gln His Ser His
Gln Met Glu Thr
Gln Met Met Val
Gln Met Thr Glu
Gln Met Val Met
Gln Ser His His
Gln Thr Glu Met
Gln Thr Met Glu
Gln Val Met Met
Arg Cys Asp Asp
Arg Cys Glu Thr
Arg Cys Thr Glu
Arg Asp Cys Asp
Arg Asp Asp Cys
Arg Asp Met Ser
Arg Asp Ser Met
Arg Glu Cys Thr
Arg Glu Thr Cys
Arg Met Asp Ser
Arg Met Ser Asp
Arg Ser Asp Met
Arg Ser Met Asp
Arg Thr Cys Glu
Arg Thr Glu Cys
Ser Cys Ile Trp
Ser Cys Leu Trp
Ser Cys Trp Ile
Ser Cys Trp Leu
Ser Asp Met Arg
Ser Asp Arg Met
Ser Asp Thr Trp
Ser Asp Trp Thr
Ser Glu Ser Trp
Ser Glu Trp Ser
Ser His His Gln
Ser Ile Cys Trp
Ser Ile Trp Cys
Ser Leu Cys Trp
Ser Leu Trp Cys
Ser Met Asp Arg
Ser Met Arg Asp
Ser Arg Asp Met
Ser Arg Met Asp
Ser Ser Glu Trp
Ser Ser Trp Glu
Ser Thr Asp Trp
Ser Thr Trp Asp
Ser Trp Cys Ile
Ser Trp Cys Leu
Ser Trp Asp Thr
Ser Trp Glu Ser
Ser Trp Ile Cys
Ser Trp Leu Cys
Ser Trp Ser Glu
Ser Trp Thr Asp
Thr Ala Met Trp
Thr Ala Trp Met
Thr Cys Glu Arg
Thr Cys Arg Glu
Thr Cys Val Trp
Thr Cys Trp Val
Thr Asp Ser Trp
Thr Asp Trp Ser
Thr Glu Cys Arg
Thr Glu Met Gln
Thr Glu Gln Met
Thr Glu Arg Cys
Thr Met Ala Trp
Thr Met Glu Gln
Thr Met Gln Glu
Thr Met Trp Ala
Thr Gln Glu Met
Thr Gln Met Glu
Thr Arg Cys Glu
Thr Arg Glu Cys
Thr Ser Asp Trp
Thr Ser Trp Asp
Thr Val Cys Trp
Thr Val Trp Cys
Thr Trp Ala Met
Thr Trp Cys Val
Thr Trp Asp Ser
Thr Trp Met Ala
Thr Trp Ser Asp
Thr Trp Val Cys
Val Cys Thr Trp
Val Cys Trp Thr
Val Met Met Gln
Val Met Gln Met
Val Gln Met Met
Val Thr Cys Trp
Val Thr Trp Cys
Val Trp Cys Thr
Val Trp Thr Cys
Trp Ala Cys Glu
Trp Ala Glu Cys
Trp Ala Met Thr
Trp Ala Thr Met
Trp Cys Ala Glu
Trp Cys Glu Ala
Trp Cys Ile Ser
Trp Cys Leu Ser
Trp Cys Ser Ile
Trp Cys Ser Leu
Trp Cys Thr Val
Trp Cys Val Thr
Trp Asp Gly Met
Trp Asp Met Gly
Trp Asp Ser Thr
Trp Asp Thr Ser
Trp Glu Ala Cys
Trp Glu Cys Ala
Trp Glu Ser Ser
Trp Gly Asp Met
Trp Gly Met Asp
Trp Ile Cys Ser
Trp Ile Ser Cys
Trp Leu Cys Ser
Trp Leu Ser Cys
Trp Met Ala Thr
Trp Met Asp Gly
Trp Met Gly Asp
Trp Met Thr Ala
Trp Ser Cys Ile
Trp Ser Cys Leu
Trp Ser Asp Thr
Trp Ser Glu Ser
Trp Ser Ile Cys
Trp Ser Leu Cys
Trp Ser Ser Glu
Trp Ser Thr Asp
Trp Thr Ala Met
Trp Thr Cys Val
Trp Thr Asp Ser
Trp Thr Met Ala
Trp Thr Ser Asp
Trp Thr Val Cys
Trp Val Cys Thr
Trp Val Thr Cys
Tyr Asp Asn Pro
Tyr Asp Pro Asn
Tyr Asn Asp Pro
Tyr Asn Pro Asp
Tyr Pro Asp Asn
Tyr Pro Asn Asp
N-(4(4-PIPERIDINOMETHYL) PYRIDYL-2-OXY)-CIS-2-BUTENE)PHTALMIDE MALEATE
(S,E)-ETHYL 7-(4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-(N-METHYLMETHYLSULFONAMIDO)PYRIMIDIN-5-YL)-5-HYDROXY-3-OXOHEPT-6-ENOATE
2-[(1E,3Z)-3-CYANO-5-(1,3,3-TRIMETHYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)-1,3-PENTADIENYL]-1,3,3-TRIMETHYL-3H-INDOLIUM PERCHLORATE
CLEBOPRIDE malATE
C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Clebopride malate is a dopamine antagonist used in the study of functional gastrointestinal disorders.
EMA401
Olodanrigan (EMA401) is a highly selective, orally active, peripherally restricted angiotensin II type 2 receptor (AT2R) antagonist. It is under development as a neuropathic pain therapeutic agent. Olodanrigan (EMA401) analgesic action appears to involve inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons[1][2][3][4].
1,3,5-tris[3-(pyridin-4-yl)-1H-pyrazol-1-yl]benzene
SRT 1460
SRT 1460, a potent Sirtuin-1 (SIRT1) activator with an EC1.5 value of 2.9 μM, shows good selectivity for activation of SIRT1 versus SIRT2 and SIRT3 (EC1.5>300 μM), and is more potent than Resveratrol and the closest sirtuin homologues[1].
Umeclidinium Bromide
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BB - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent Umeclidinium bromide is a novel mAChR antagonist. The affinity (Ki) of Umeclidinium bromide for the cloned human M1-M5 mAChRs ranges from 0.05 to 0.16 nM.
2-[[[2-Amino-1-(3-methoxypropyl)-3-pyrrolo[3,2-b]quinoxalinyl]-oxomethyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid ethyl ester
N-alpha-(2-Naphthylsulfonyl)-N(3-amidino-L-phenylalaninyl)-4-acetyl-piperazine
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)nonan-1-imine
(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3S,4R,5R,6S)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxypropanoyl]amino]propanoyl]amino]pentanedioic acid
(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3S,4R,5R,6R)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxypropanoyl]amino]propanoyl]amino]pentanedioic acid
(1R,2R,5S,8S,9S,10R,11R,12S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-12-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylate
N-[4-[[2-methoxy-5-[4-oxo-3-(phenylmethyl)-1,2-dihydroquinazolin-2-yl]phenyl]methoxy]phenyl]acetamide
(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(1-methylimidazol-4-yl)sulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-(1-methylimidazol-4-yl)sulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-[(1-methyl-4-imidazolyl)sulfonyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-[(1-methyl-4-imidazolyl)sulfonyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide
(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-[(1-methyl-4-imidazolyl)sulfonyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-(2-thiazolylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide
N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide
Ibiglustat (succinate)
Ibiglustat (Venglustat) succinate is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat succinate can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease[1][2].
NTNCB (hydrochloride)
NTNCB (Compound 11) hydrochloride is a potent and selective neuropeptide Y Y5 (NPY Y5) receptor antagonist with a Ki of 8 nM against human Y5[1].
(1r,2r,4s,6s,7s,9s,10s,11s,12r,13s,14r)-2,4,6,9,11,13,14-heptahydroxy-11-isopropyl-7,10-dimethyl-3-methylidene-15-oxapentacyclo[7.5.1.0¹,⁶.0⁷,¹³.0¹⁰,¹⁴]pentadecan-12-yl 1h-pyrrole-2-carboxylate
n-[(2r,3r,4r,6r)-6-{[(3s)-3-ethyl-6-hydroxy-1,7,12-trioxo-3,4-dihydro-2h-tetraphen-8-yl]oxy}-3-hydroxy-2-methyloxan-4-yl]ethanimidic acid
(1'r,2s,2'r,6's,7's,9's,10's,11's,12'r,13's,14'r)-2',6',9',11',13',14'-hexahydroxy-11'-isopropyl-7',10'-dimethyl-15'-oxaspiro[oxirane-2,3'-pentacyclo[7.5.1.0¹,⁶.0⁷,¹³.0¹⁰,¹⁴]pentadecan]-12'-yl 1h-pyrrole-2-carboxylate
(12r,15s)-9-ethyl-4,18-dihydroxy-12-(1-hydroxyethyl)-3,15-dimethyl-13-oxa-19-azatetracyclo[18.3.1.0⁵,²³.0¹⁵,²¹]tetracosa-1(23),2,4,10,16,18,20-heptaene-6,14,22,24-tetrone
(13s)-8,9-dehydro-18-hydroxy-10-epi-ryanodine
{"Ingredient_id": "HBIN001300","Ingredient_name": "(13s)-8,9-dehydro-18-hydroxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4930","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
20-norspiganthine-5-carboxylicacid
{"Ingredient_id": "HBIN003424","Ingredient_name": "20-norspiganthine-5-carboxylicacid","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "CC1CCC2(C3(CC4(C5(C(C3C(C5(C(C)C)O)OC(=O)C6=CC=CN6)(C2(C1O)O4)O)C)O)C(=O)O)O","Ingredient_weight": "507.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15785","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101131109","DrugBank_id": "NA"}
3'-hydroxy-n-demethylrocaglamide
{"Ingredient_id": "HBIN008730","Ingredient_name": "3'-hydroxy-n-demethylrocaglamide","Alias": "NA","Ingredient_formula": "C28H29NO8","Ingredient_Smile": "CNC(=O)C1C(C2(C(C1O)(C3=C(C=C(C=C3O2)OC)OC)O)C4=CC(=C(C=C4)OC)O)C5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9980","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-deoxy-6β,9β-epoxy-8α-hydroxy-10-epi-ryano-dine
{"Ingredient_id": "HBIN012313","Ingredient_name": "6-deoxy-6\u03b2,9\u03b2-epoxy-8\u03b1-hydroxy-10-epi-ryano-dine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5168","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8,9-dehydro-20-hydroxy-10-epi-ryanodine
{"Ingredient_id": "HBIN013585","Ingredient_name": "8,9-dehydro-20-hydroxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4931","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8,9-dehydro-21-hydroxy-10-epi-ryanodine
{"Ingredient_id": "HBIN013586","Ingredient_name": "8,9-dehydro-21-hydroxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4932","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8α,9α-epoxy-10-epi-ryanodine
{"Ingredient_id": "HBIN013613","Ingredient_name": "8\u03b1,9\u03b1-epoxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "CC(C)C1(C(C2(C3(CC4(C1(C2(C5(C3(CC6C(C5O)(O6)C)O)O4)O)C)O)C)O)OC(=O)C7=CC=CN7)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7090","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8β,9β-epoxy-10-epi-ryanodine
{"Ingredient_id": "HBIN013655","Ingredient_name": "8\u03b2,9\u03b2-epoxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "CC(C)C1(C(C2(C3(CC4(C1(C2(C5(C3(CC(C(=C)C5O)O)O)O4)O)C)O)C)O)OC(=O)C6=CC=CN6)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7091","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}